NIPRO CORPORATION manufactures medical products.  The Company's products include artificial dialysis and blood transfusion equipment, hypodermic syringes, and glass products for medical use.

[Summary] Consolidated Financial Results For The Six Months Ended September 30, 2025 (Under Japanese Gaap)

Notice Regarding Difference Between Consolidated Financial Forecasts And Actual Results For The Six Months Ended September 30, 2025

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Nipro Corp (8086 JP)

[Summary] Consolidated Financial Results For The Six Months Ended September 30, 2025 (Under Japanese Gaap)

Notice Regarding Difference Between Consolidated Financial Forecasts And Actual Results For The Six Months Ended September 30, 2025

Notice Concerning Acquisition Of Shares Of G2spryte Holdco Llc (To Make It A Subsidiary)

Notice Of Regarding Transfer Of Beneficial Interest In Domestic Real Estate (Land) Trust And Extraordinary Gains

Notice Of Partial Amendments To The Articles Of Incorporation

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)